General Information
Revision date
2020-11-12
Product name
100 mg, 150 mg, 200 mg, 225 mg, and 300 mg
Product name
100 mg, 150 mg, 200 mg, 225 mg, and 300 mg
Identification on the label/Trade name
Not Applicable
Product Synonyms
Pharmaceutical product for the treatment of
1.2.1 Relevant identified uses
Management of neuropathic pain associated with diabetic peripheral neuropathy Hetero Labs Limited, Unit-III
Manufacturer Name
Plot No. 22-110
Icons in SDS
Company Information
company name
Plot No. 22-110
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361d
Hazard statements
Code
Statements
H361d
Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
Classification of the Substance or Mixture GHS - Classification Reproductive Toxicity: Category 2
Signal word
Warning
Hazard statements
H361d - Suspected of damaging the unborn child P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P308 + P313 - IF exposed or concerned: Get
Precautionary statements
medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations An Occupational Exposure Value has been
2.3 Other hazards
established for one or more of the ingredients (see Section 8). This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. Note The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
GHS - Classification Reproductive Toxicity: Category 2
